heart disease

Digital

ECG data and AI will fuel pharma’s next drug development and...

Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.

R&D

Modernising clinical trials: The PARTICIPATE framework

Each year, a staggering 67 million individuals lose their lives.1 Heart disease account for approximately 17.9 million of these deaths,2 and cancer takes away 10 milli

R&D

Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical rese

News

New treatments for heart disease

Heart failure

News

Boehringer Ingelheim, Biberach, Germany, February 2007

FDA approves Jardiance (empagliflozin) for wider range of pa...

Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin) has been granted approval by the US Food and Drug Administration (FDA) for a wider range of heart fa

News